AVR:NASDAQ, Anteris Technologies Global Corp.

AVR stock overview

Anteris Technologies Global Corp. (AVR:NASDAQ) closed at $4.99 on November 20, 2026, down 1.96% on the day. The stock trades 54.9% below its 52-week high of $11.06 and 51.2% above its 52-week low of $3.30. Over the past year, it gained 33.8%. Anteris Technologies Global Corp. is part of the Health Care sector.

Key figures

Price
$4.99
Day change
-1.96%
Volume
1,537,886
Average volume
1,157,632
Market cap
486M+
52-week range
$3.30 – $11.06
50-day average
$6.70
200-day average
$7.37

Price action over the past year

In 252 trading sessions since November 20, 2025, AVR closed higher on 124 days (49%). Its best day was December 18, 2025 (+15.40%) and its worst was December 19, 2025 (-9.69%). The stock moved 10% or more in a single session 5 times. It opened at least 5% above the previous day's high 1 time.

Recent signals

AVR news

About Anteris Technologies Global Corp.

Anteris Technologies Global Corp. is a structural heart company committed to discovering, developing and commercializing innovative medical devices designed to improve the quality of life for patients with aortic stenosis. Our lead product, the DurAVR® transcatheter heart valve ("THV") system, represents a unique product opportunity in a new THV class of single-piece heart valves, for the treatment of aortic stenosis. Our DurAVR® THV System consists of a single-piece, biomimetic valve made with our proprietary ADAPT® tissue-enhancing technology and depoloyed with our ComASUR® balloon-expahndable delivery system. ADAPT® is our proprietary anti-calcification tissue shaping technology that is designed to reengineer xenograft tissue into a pure, single-piece collagen bioscaffold.

Similar stocks

Find more stocks like AVR with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.